Literature DB >> 26852229

Mood stabilizing drugs regulate transcription of immune, neuronal and metabolic pathway genes in Drosophila.

L Herteleer1,2,3, L Zwarts1,2,3, K Hens1,2,3,4, D Forero1,2,3,5,6,7, J Del-Favero5,6, P Callaerts8,9,10.   

Abstract

RATIONALE: Lithium and valproate (VPA) are drugs used in the management of bipolar disorder. Even though they reportedly act on various pathways, the transcriptional targets relevant for disease mechanism and therapeutic effect remain unclear. Furthermore, multiple studies used lymphoblasts of bipolar patients as a cellular proxy, but it remains unclear whether peripheral cells provide a good readout for the effects of these drugs in the brain.
OBJECTIVES: We used Drosophila culture cells and adult flies to analyze the transcriptional effects of lithium and VPA and define mechanistic pathways.
METHODS: Transcriptional profiles were determined for Drosophila S2-cells and adult fly heads following lithium or VPA treatment. Gene ontology categories were identified using the DAVID functional annotation tool with a cut-off of p < 0.05. Significantly enriched GO terms were clustered using REVIGO and DAVID functional annotation clustering. Significance of overlap between transcript lists was determined with a Fisher's exact hypergeometric test.
RESULTS: Treatment of cultured cells and adult flies with lithium and VPA induces transcriptional responses in genes with similar ontology, with as most prominent immune response, neuronal development, neuronal function, and metabolism.
CONCLUSIONS: (i) Transcriptional effects of lithium and VPA in Drosophila S2 cells and heads show significant overlap. (ii) The overlap between transcriptional alterations in peripheral versus neuronal cells at the single gene level is negligible, but at the gene ontology and pathway level considerable overlap can be found. (iii) Lithium and VPA act on evolutionarily conserved pathways in Drosophila and mammalian models.

Entities:  

Keywords:  Bipolar disorder; Drosophila; Immune; Lithium; Transcriptional profiling; Valproate

Mesh:

Substances:

Year:  2016        PMID: 26852229     DOI: 10.1007/s00213-016-4223-z

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  55 in total

1.  Evidence-based health policy--lessons from the Global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Science       Date:  1996-11-01       Impact factor: 47.728

2.  Lithium- and valproate-induced alterations in circadian locomotor behavior in Drosophila.

Authors:  Mehmet E Dokucu; Liangping Yu; Paul H Taghert
Journal:  Neuropsychopharmacology       Date:  2005-12       Impact factor: 7.853

3.  Chronic lithium treatment of B lymphoblasts from bipolar disorder patients reduces transient receptor potential channel 3 levels.

Authors:  S Andreopoulos; M Wasserman; K Woo; P P Li; J J Warsh
Journal:  Pharmacogenomics J       Date:  2004       Impact factor: 3.550

4.  The emerging epidemiology of hypomania and bipolar II disorder.

Authors:  J Angst
Journal:  J Affect Disord       Date:  1998-09       Impact factor: 4.839

5.  Lithium toxicity and expression of stress-related genes or proteins in A549 cells.

Authors:  M S Allagui; C Vincent; A El feki; Y Gaubin; F Croute
Journal:  Biochim Biophys Acta       Date:  2007-04-21

6.  A comparative transcriptomic study on the effects of valproic acid on two different hESCs lines in a neural teratogenicity test system.

Authors:  Silvia Colleoni; Cesare Galli; John Antony Gaspar; Kesavan Meganathan; Smita Jagtap; Jurgen Hescheler; Dimitra Zagoura; Susanne Bremer; Agapios Sachinidis; Giovanna Lazzari
Journal:  Toxicol Lett       Date:  2014-09-02       Impact factor: 4.372

Review 7.  [Brain-immune interactions and implications in psychiatric disorders].

Authors:  Andrea H Marques; Giovanni Cizza; Esther Sternberg
Journal:  Braz J Psychiatry       Date:  2007-05       Impact factor: 2.697

8.  Analyzing gene expression profile in K562 cells exposed to sodium valproate using microarray combined with the connectivity map database.

Authors:  Xiang-Zhong Zhang; Ai-Hua Yin; Dong-Jun Lin; Xiao-Yu Zhu; Qian Ding; Chun-Huai Wang; Yun-Xian Chen
Journal:  J Biomed Biotechnol       Date:  2012-06-04

9.  The histone deacetylase inhibitor sodium valproate causes limited transcriptional change in mouse embryonic stem cells but selectively overrides Polycomb-mediated Hoxb silencing.

Authors:  Elsa Boudadi; Hannah Stower; John A Halsall; Charlotte E Rutledge; Martin Leeb; Anton Wutz; Laura P O'Neill; Karl P Nightingale; Bryan M Turner
Journal:  Epigenetics Chromatin       Date:  2013-05-01       Impact factor: 4.954

10.  FlyBase 102--advanced approaches to interrogating FlyBase.

Authors:  Susan E St Pierre; Laura Ponting; Raymund Stefancsik; Peter McQuilton
Journal:  Nucleic Acids Res       Date:  2013-11-13       Impact factor: 16.971

View more
  3 in total

1.  Immune influences on the brain: new findings and implications for treatment.

Authors:  Theodora Duka; Neil A Harrison; Oliver D Howes
Journal:  Psychopharmacology (Berl)       Date:  2016-05       Impact factor: 4.530

2.  Transcriptional analysis of sodium valproate in a serotonergic cell line reveals gene regulation through both HDAC inhibition-dependent and independent mechanisms.

Authors:  Priyanka Sinha; Simone L Cree; Allison L Miller; John F Pearson; Martin A Kennedy
Journal:  Pharmacogenomics J       Date:  2021-03-01       Impact factor: 3.550

3.  Serotonin modulates a depression-like state in Drosophila responsive to lithium treatment.

Authors:  Ariane-Saskia Ries; Tim Hermanns; Burkhard Poeck; Roland Strauss
Journal:  Nat Commun       Date:  2017-06-06       Impact factor: 14.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.